secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevation Oncology, Inc. (—)
CIK:        0001783032
Form:       8-K
Filed at:   2025-03-19T23:59:59+00:00
Accession:  0001558370-25-003305
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevation Oncology transfers to Nasdaq Capital Market; granted 180-day bid price cure period
--------------------------------------------------------------------------------

- Transfer from Nasdaq Global Select to Nasdaq Capital Market effective March 21, 2025.
- Company noncompliant with $1.00 minimum bid price for 30 consecutive days as of Sept 2024.
- Nasdaq granted additional 180 days, until September 15, 2025, to regain compliance.
- To cure, closing bid price must hit $1.00 for 10 consecutive business days by that date.
- Company will monitor and consider options including a reverse stock split if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783032/000155837025003305/0001558370-25-003305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783032/000155837025003305/elev-20250319x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-003305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer